eFFECTOR Therapeutics, Inc. - EFTR
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q2 2024
· Q1 2024
Value (USD)
Total reported value ($000)
$201K
QoQ value delta ($000)
-$7.908M
(-97.52%)
Implied price effect (QoQ)
-98.02%
Shares
Total shares
710,647
QoQ shares delta
+143,141
(+25.22%)
Total shares held by funds (by quarter)
Market chart (EFTR)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q2 2024)
Top 25 only
Full list
Early Q1 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 105 | 364,934 | 0.0% |
| Carlyle Group Inc. | 55 | 192,884 | 0.01% |
| UBS Group AG | 17 | 61,667 | 0.0% |
| VANGUARD GROUP INC | 7 | 25,070 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 7 | 25,583 | 0.0% |
| JANE STREET GROUP, LLC | 5 | 18,669 | 0.0% |
| TWO SIGMA INVESTMENTS, LP | 3 | 11,115 | 0.0% |
| Tower Research Capital LLC (TRC) | 2 | 9,805 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 0 | 31 | 0.0% |
| BARCLAYS PLC | 0 | 100 | 0.0% |
| MORGAN STANLEY | 0 | 240 | 0.0% |
| ROYAL BANK OF CANADA | 0 | 546 | 0.0% |
| Qube Research & Technologies Ltd | 0 | 3 | 0.0% |